It is important to note that isoform-specific Notch-receptor targeting has been more difficult to develop than ligand targeting; furthermore, one study examining the role of Notch2 in podocytes in nephrotic syndrome indicated some potential benefit [54]. The gene discussed is NOTCH2; the disease is nephrotic syndrome.